Criteria for safety evaluation of antimicrobial agents

Journal of Infection and Chemotherapy

Volumn 17, Issue 1, 2011, Pages 139-147

  Watanabe, Akira ^a,o   Tokue, Yutaka ^b   Aoki, Nobuki ^c   Matsumoto, Tetsuro ^d   Yanagihara, Katsunori ^e   Higa, Futoshi ^f   Tsuge, Hiroyuki ^g   Nagashima, Masahito ^h   Matsuoka, Hiromi ^g   Sasagawa, Yuji ⁱ   Matsumoto, Masato ⁱ   Fujimaki, Kazuo ^j   Taguchi, Kenji ^j   Ariyasu, Mari ^k   Yamamoto, Norifumi ^l   Kunii, Otohiko ^m   Shiba, Kohya ⁿ  

^a TOHOKU UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY HOSPITAL   (Japan)

^c Shinrakuen Hospital   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^e NAGASAKI UNIVERSITY   (Japan)

^f UNIVERSITY OF THE RYUKYUS   (Japan)

^g DAIICHI SANKYO CO   (Japan)

^h PFIZER INC   (United States)

ⁱ MEIJI SEIKA KAISHA LTD   (Japan)

^j TOYAMA CHEMICAL CO LTD   (Japan)

^k SHIONOGI AND CO LTD   (Japan)

^l Sanofi Aventis KK ^*  (Japan)

^m TEIKYO UNIVERSITY   (Japan)

ⁿ JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o Japanese Society of Chemotherapy   (Japan)

more..

Author keywords

Antimicrobial agent; Clinical trial; Safety evaluation criteria

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIINFECTIVE AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHLORIDE; CREATINE KINASE; CREATININE; CYTOSOL AMINOPEPTIDASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN; LACTATE DEHYDROGENASE; POTASSIUM; SODIUM;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL TENDERNESS; ABNORMAL LABORATORY RESULT; ABNORMAL SENSATION; ACNE; ACUTE SINUSITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLERGIC RHINITIS; ANOREXIA; ANTIPHOSPHOLIPID SYNDROME; ANXIETY DISORDER; APPLICATION SITE EXCORIATION; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; ASTHMA; ATTENTION DISTURBANCE; BACKACHE; BALANITIS; BILIRUBIN BLOOD LEVEL; BLOOD DISEASE; BLURRED VISION; BRAIN INFARCTION; BREAST DISEASE; BURSITIS; CATARACT; CHEILITIS; CHILL; CHLORIDE BLOOD LEVEL; CHONDROCALCINOSIS; COLD SWEAT; CONJUNCTIVAL HYPEREMIA; CONNECTIVE TISSUE DISEASE; CONSTIPATION; CONTACT DERMATITIS; CONTUSION; CONVERSION DISORDER; COUGHING; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; CYANOSIS; CYLINDROMA; DEATH; DECREASED APPETITE; DECUBITUS; DEPRESSION; DIARRHEA; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DYSARTHRIA; DYSGEUSIA; DYSPEPSIA; DYSPNEA; DYSURIA; EAR DISEASE; ECZEMA; EOSINOPHIL COUNT; EPIGASTRIC DISCOMFORT; EPISTAXIS; ERYTHEMA; ERYTHROCYTE COUNT; EYE DISEASE; EYELID EDEMA; FALLING; FEVER; FISTULA; FLANK PAIN; FLATULENCE; GAIT DISORDER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTRITIS; GASTROINTESTINAL DISEASE; GENITAL PRURITUS; GINGIVA PAIN; GINGIVITIS; GLOSSITIS; GLOSSODYNIA; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HARD FECES; HEADACHE; HEARING IMPAIRMENT; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART PALPITATION; HEART VENTRICLE EXTRASYSTOLE; HEAT RASH; HEMATOCHEZIA; HEMATOCRIT; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HEMOPTYSIS; HERPES SIMPLEX; HERPES ZOSTER; HORDEOLUM; HOT FLUSH; HUMAN; HYPERCHLORHYDRIA; HYPERHIDROSIS; HYPERSALIVATION; HYPERTENSION; HYPESTHESIA; IMMUNOPATHOLOGY; INFLUENZA; INJECTION SITE BLEEDING; INJECTION SITE PAIN; INJECTION SITE PHLEBITIS; INJURY; INNER EAR DISEASE; INSOMNIA; INTERSTITIAL LUNG DISEASE; IRRITABLE COLON; KIDNEY DISEASE; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LIMB DISEASE; LOEFFLER PNEUMONIA; LOOSE FECES; LOWER ABDOMINAL PAIN; LUNG EDEMA; LUNG FIBROSIS; LUNG INFARCTION; LYMPHADENITIS; LYMPHATIC SYSTEM DISEASE; MACULOPAPULAR RASH; MALAISE; MEDIASTINUM DISEASE; MELENA; MENOPAUSAL SYNDROME; MENTAL DISEASE; MENTAL INSTABILITY; METABOLIC DISORDER; MOUTH DISCOMFORT; MOUTH PAIN; MUSCLE HYPOTONIA; MUSCLE SPASM; MUSCLE TIGHTNESS; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; MYALGIA; NAUSEA; NECK PAIN; NEUROLOGIC DISEASE; NEUROSIS; NOSE CONGESTION; NUTRITIONAL DISORDER; OBSTRUCTIVE AIRWAY DISEASE; ORAL PARESTHESIA; PALLOR; PAPULAR RASH; PARESTHESIA; PAROTID ENLARGEMENT; PERIPHERAL EDEMA; PERONEUS NERVE PARALYSIS; PHARYNGITIS; PHARYNX DISEASE; PHOTOSENSITIVITY DISORDER; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; POLLAKISURIA; POSITIONAL DIZZINESS; POSITIONAL VERTIGO; POTASSIUM BLOOD LEVEL; PSEUDOMEMBRANOUS COLITIS; PURPURA; RADIATION PNEUMONIA; RESIDUAL URINE; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; RESTLESSNESS; RHINOPHARYNGITIS; RHINORRHEA; RIB FRACTURE; SALIVARY GLAND DISEASE; SEBORRHEIC DERMATITIS; SHOCK; SHOULDER PAIN; SIDE EFFECT; SINUS TACHYCARDIA; SKIN DISEASE; SNEEZING; SODIUM BLOOD LEVEL; SOMNOLENCE; SORE THROAT; SPINE FRACTURE; SPRAIN; STOMACH DISCOMFORT; STOMACH DISEASE; STOMATITIS; SYNCOPE; THIRST; THORAX DISEASE; THORAX PAIN; THROMBOCYTE COUNT; TINEA PEDIS; TINNITUS; TONGUE DISEASE; TONSILLITIS; TREMOR; UPPER ABDOMINAL PAIN; UPPER RESPIRATORY TRACT INFECTION; UREA NITROGEN BLOOD LEVEL; URETHRAL BLEEDING; URINE INCONTINENCE; UROGENITAL TRACT DISEASE; URTICARIA; VAGINA CANDIDIASIS; VASCULAR DISEASE; VERTEBRA FRACTURE; VOMITING; XEROSTOMIA;

EID: 79951553517     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-010-0183-0     Document Type: Article

References (6)

1. Japanese Society of Chemotherapy 1991 Criteria for assessment of adverse reactions and abnormal laboratory values associated with antimicrobial agents in study subjects Jpn J Chemother 39 687 689
2. Japanese Society of Chemotherapy. About the partial modification of "Criteria for assessment of adverse reactions and abnormal laboratory values associated with antimicrobial agents in study subjects". Jpn J Chemother. 1995; 43 (the opening article).
3. JCOG/JSCO 2004 Common Terminology Criteria for Adverse Events (CTCAE) v3.0 for Japanese Int J Clin Oncol 9 Supp III 1 82
4. Japanese Society of Chemotherapy 2009 Committee interim report: criteria for assessment of abnormal laboratory values associated with antimicrobial agents (draft v.0.2) Jpn J Chemother 57 320 342
5. The international conference on harmonization of technical requirements for registration of pharmaceuticals for human Use (ICH). Clinical safety data management: definitions and standards for expedited reporting. ICH harmonized tripartite guideline. Recommended for Adoption at Step 4 of the ICH Process on 27 October 1994.
6. Japanese Society of Chemotherapy. Criteria for assessment of antimicrobial agents in pediatric clinical study. Jpn J Chemother 2003; 51:144-51.